Search

everythinglearnresearchcommunity

for

Search:↓

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone is crucial for development, growth, and various body functions in mammals.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.